FGF2 and neoplasm: The sphere-forming assay for CSC enrichment uses a serum-free medium supplemented with appropriate mitogens such as epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), b27 and N2 supplements in a low adherence system to form tumour spheres that exhibit self-renewal and tumourigenicity [53].